ID, description, units |
MPD:16203
TST_preRx TST duration of immobility, treatment group, 6 min test
[s] baseline
imipramine study |
Data set, strains | Gershenfeld1 inbred 12 strains sex: m age: 5-10wks |
Procedure | tail suspension test |
Strain | Sex | Measured Value |
Z score within strain/sex group |
Animal ID |
---|---|---|---|---|
m | 257 | 0.24 | xq11e | |
m | 229 | -1.39 | xq11a | |
m | 265 | 0.71 | xq11b | |
m | 271 | 1.06 | xq11c | |
m | 242 | -0.63 | xq11d | |
m | 238 | 0.10 | xq19e | |
m | 249 | 0.70 | xq19d | |
m | 258 | 1.18 | xq19c | |
m | 223 | -0.72 | xq19b | |
m | 213 | -1.26 | xq19a | |
m | 147 | -0.59 | xq1-a | |
m | 247 | 1.46 | xq1-b | |
m | 203 | 0.56 | xq1-c | |
m | 125 | -1.04 | xq1-d | |
m | 157 | -0.38 | xq1-e | |
m | 271 | 0.98 | xq23a | |
m | 263 | 0.66 | xq23e | |
m | 207 | -1.61 | xq23d | |
m | 249 | 0.09 | xq23c | |
m | 244 | -0.11 | xq23b | |
m | 298 | 1.01 | C3Hb4 | |
m | 243 | -0.16 | C3Hb5 | |
m | 203 | -1.02 | C3Hb3 | |
m | 209 | -0.89 | C3Ha5 | |
m | 300 | 1.06 | C3Ha4 | |
m | 273 | 1.43 | xq21a | |
m | 236 | -0.37 | xq21e | |
m | 253 | 0.46 | xq21d | |
m | 218 | -1.24 | xq21c | |
m | 238 | -0.27 | xq21b | |
m | 138 | -1.00 | xq16e | |
m | 173 | -0.23 | xq16a | |
m | 237 | 1.19 | xq16b | |
m | 145 | -0.85 | xq16c | |
m | 224 | 0.90 | xq16d | |
m | 234 | 0.31 | xq3-a | |
m | 211 | -0.77 | xq3-e | |
m | 260 | 1.52 | xq3-d | |
m | 206 | -1.00 | xq3-c | |
m | 226 | -0.07 | xq3-b | |
m | 226 | -0.70 | xq7-e | |
m | 262 | 0.63 | xq7-a | |
m | 268 | 0.85 | xq7-b | |
m | 207 | -1.41 | xq7-c | |
m | 262 | 0.63 | xq7-d | |
m | 277 | 0.94 | lp1.2 | |
m | 273 | 0.64 | lp4.3 | |
m | 247 | -1.33 | lp4.1 | |
m | 271 | 0.49 | lp3.2 | |
m | 274 | 0.71 | lp2.3 | |
m | 245 | -1.48 | lp2.1 | |
m | 265 | 0.03 | lp1.4 | |
m | 266 | 0.33 | xq9-a | |
m | 258 | 0.10 | SCA2 | |
m | 298 | 1.24 | SCA1 | |
m | 201 | -1.53 | xq9-e | |
m | 250 | -0.13 | xq9-c | |
m | 243 | 0.16 | xq5-c | |
m | 219 | -0.87 | xq5-b | |
m | 272 | 1.42 | xq5-a | |
m | 215 | -1.05 | xq5-e | |
m | 247 | 0.34 | xq5-d |